NKX2-4
geneOn this page
Also known as NKX2.4
Summary
NKX2-4 (NK2 homeobox 4, HGNC:7837) is a protein-coding gene on chromosome 20p11.22, encoding Homeobox protein Nkx-2.4 (Q9H2Z4). Probable transcription factor.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in cell differentiation and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.
Source: NCBI Gene 644524 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 80 total — 1 pathogenic
- MANE Select transcript:
NM_033176
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7837 |
| Approved symbol | NKX2-4 |
| Name | NK2 homeobox 4 |
| Location | 20p11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NKX2.4 |
| Ensembl gene | ENSG00000125816 |
| Ensembl biotype | protein_coding |
| OMIM | 607808 |
| Entrez | 644524 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000351817
RefSeq mRNA: 1 — MANE Select: NM_033176
NM_033176
CCDS: CCDS42855
Canonical transcript exons
ENST00000351817 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001365647 | 21396958 | 21397526 |
| ENSE00001472930 | 21395365 | 21396533 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 84.32.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1677 / max 48.6944, expressed in 31 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 186601 | 0.1065 | 27 |
| 186600 | 0.0612 | 23 |
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.99 | gold quality |
| right testis | UBERON:0004534 | 49.26 | gold quality |
| testis | UBERON:0000473 | 48.77 | gold quality |
| left testis | UBERON:0004533 | 48.27 | gold quality |
| hypothalamus | UBERON:0001898 | 43.61 | gold quality |
| ventricular zone | UBERON:0003053 | 40.13 | gold quality |
| bone marrow cell | CL:0002092 | 39.99 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| adenohypophysis | UBERON:0002196 | 36.39 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| granulocyte | CL:0000094 | 35.31 | gold quality |
| bone marrow | UBERON:0002371 | 33.70 | gold quality |
| pituitary gland | UBERON:0000007 | 33.40 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| prefrontal cortex | UBERON:0000451 | 31.29 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.57 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 30.22 | silver quality |
| superior frontal gyrus | UBERON:0002661 | 29.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| leukocyte | CL:0000738 | 29.68 | gold quality |
| liver | UBERON:0002107 | 29.46 | gold quality |
| monocyte | CL:0000576 | 29.33 | gold quality |
| placenta | UBERON:0001987 | 29.28 | gold quality |
| substantia nigra | UBERON:0002038 | 28.74 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.00 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2003.1 | NKX2-4 | NK |
| MA2003.2 | NKX2-4 | NK |
JASPAR matrix evidence (PMIDs): PMID:18585359
miRNA regulators (miRDB)
32 targeting NKX2-4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-25-3P | 99.98 | 74.60 | 1817 |
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-409-3P | 99.50 | 66.33 | 1192 |
| HSA-MIR-4325 | 99.49 | 72.20 | 1342 |
| HSA-MIR-20B-3P | 99.29 | 67.05 | 784 |
| HSA-MIR-224-3P | 98.91 | 68.42 | 1815 |
| HSA-MIR-522-3P | 98.91 | 68.56 | 1817 |
| HSA-MIR-6780A-3P | 98.42 | 67.49 | 1518 |
| HSA-MIR-6509-3P | 98.32 | 67.33 | 1343 |
| HSA-MIR-6881-3P | 98.04 | 68.24 | 1777 |
| HSA-MIR-3921 | 97.81 | 67.45 | 1431 |
| HSA-MIR-7111-3P | 97.80 | 66.75 | 1467 |
| HSA-MIR-7703 | 97.64 | 67.00 | 965 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-4653-5P | 97.22 | 67.72 | 1429 |
| HSA-MIR-4445-5P | 97.21 | 66.16 | 832 |
| HSA-MIR-4436B-5P | 96.71 | 68.37 | 1346 |
Literature-anchored findings (GeneRIF, showing 2)
- NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML. (PMID:34768865)
- Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor. (PMID:36459980)
Cross-species orthologs
11 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nkx2.4a | ENSDARG00000075107 |
| danio_rerio | nkx2.4b | ENSDARG00000104107 |
| mus_musculus | Nkx2-4 | ENSMUSG00000054160 |
| rattus_norvegicus | Nkx2-4 | ENSRNOG00000012647 |
| drosophila_melanogaster | NK7.1 | FBGN0024321 |
| drosophila_melanogaster | HGTX | FBGN0040318 |
| drosophila_melanogaster | scro | FBGN0287186 |
| caenorhabditis_elegans | ceh-9 | WBGENE00000434 |
| caenorhabditis_elegans | WBGENE00000447 | |
| caenorhabditis_elegans | WBGENE00000450 | |
| caenorhabditis_elegans | WBGENE00000584 |
Paralogs (13): NKX3-2 (ENSG00000109705), NKX2-3 (ENSG00000119919), NKX2-2 (ENSG00000125820), NKX2-8 (ENSG00000136327), NKX2-1 (ENSG00000136352), NKX6-2 (ENSG00000148826), NKX6-1 (ENSG00000163623), NKX6-3 (ENSG00000165066), NKX3-1 (ENSG00000167034), NKX2-6 (ENSG00000180053), NKX2-5 (ENSG00000183072), NKX1-2 (ENSG00000229544), NKX1-1 (ENSG00000235608)
Protein
Protein identifiers
Homeobox protein Nkx-2.4 — Q9H2Z4 (reviewed: Q9H2Z4)
Alternative names: Homeobox protein NK-2 homolog D
All UniProt accessions (1): Q9H2Z4
UniProt curated annotations — full annotation on UniProt →
Function. Probable transcription factor.
Subcellular location. Nucleus.
Similarity. Belongs to the NK-2 homeobox family.
RefSeq proteins (1): NP_149416* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR020479 | HD_metazoa | Domain |
| IPR050394 | Homeobox_NK-like | Family |
Pfam: PF00046
UniProt features (6 total): sequence conflict 2, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H2Z4-F1 | 59.61 | 0.20 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
chr20p11, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MEISSNER_BRAIN_HCP_WITH_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, MIR32_5P, MIR92A_3P, MIR92B_3P, MIR367_3P, MIR363_3P, MIR25_3P, MIR4325
GO Biological Process (5): regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154), positive regulation of transcription by RNA polymerase II (GO:0045944), animal organ development (GO:0048513), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)
GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription cis-regulatory region binding | 2 |
| cellular developmental process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| anatomical structure development | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| nucleic acid binding | 1 |
| transcription regulator activity | 1 |
| binding | 1 |
| chromosome | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
594 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NKX2-4 | DCUN1D1 | Q96GG9 | 900 |
| NKX2-4 | C8orf74 | Q6P047 | 543 |
| NKX2-4 | KIZ | Q2M2Z5 | 507 |
| NKX2-4 | XRN2 | Q9H0D6 | 445 |
| NKX2-4 | NKX2-2 | O95096 | 381 |
| NKX2-4 | FOXB2 | Q5VYV0 | 367 |
| NKX2-4 | SFTPB | P07988 | 354 |
| NKX2-4 | PAX1 | P15863 | 351 |
| NKX2-4 | ZNF300 | Q96RE9 | 348 |
| NKX2-4 | KAT14 | Q9H8E8 | 347 |
| NKX2-4 | NKX6-3 | A6NJ46 | 346 |
| NKX2-4 | LMX1B | O60663 | 346 |
| NKX2-4 | CRNKL1 | Q9BZJ0 | 343 |
| NKX2-4 | LHX6 | Q9UPM6 | 342 |
| NKX2-4 | IRX3 | P78415 | 329 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOTO | NKX2-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ETV7 | NFIB | psi-mi:“MI:2364”(proximity) | 0.470 |
| NKX2-5 | psi-mi:“MI:0914”(association) | 0.350 | |
| AIM2 | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| ARGLU1 | PIAS2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| NFIB | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PAX2 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| PAX8 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SOX17 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SP7 | IGF2BP3 | psi-mi:“MI:2364”(proximity) | 0.270 |
| TBR1 | BCL9 | psi-mi:“MI:2364”(proximity) | 0.270 |
| NKX2-4 | NOTO | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): NOTO (Two-hybrid), NKX2-4 (Affinity Capture-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS)
ESM2 similar proteins: A1YER7, A1YF08, A1YFD8, A1YFY3, A1YG85, A2D4P8, A2D4R4, A2D5I1, A2D649, A2T6H5, A2T6X6, A2T6Z0, A2T756, A2T7H5, A2T7J2, O35767, O43186, O88470, P06798, P09016, P10284, P10628, P17277, P17483, P18111, P23813, P31260, P31277, P31310, P42582, P43241, P43345, P47902, P52945, P52946, P52947, P52952, P57073, P58012, P70118
Diamond homologs: A1YF16, A1YG93, A2RU54, A2T764, A6NCS4, A6NHT5, G5EE18, O02786, O15522, O17319, O35767, O43763, O57601, O70218, O70584, O93590, O95096, P13297, P22711, P22808, P22809, P23410, P23441, P28360, P28361, P28362, P35548, P35993, P40764, P41936, P42581, P42582, P42583, P42584, P42586, P42587, P43687, P43688, P43697, P43698
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 76 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3068496 | NC_000020.10:g.19434987_22528253del | Pathogenic |
SpliceAI
210 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:21396956:A:AC | donor_gain | 0.9900 |
| 20:21396957:C:CC | donor_gain | 0.9900 |
| 20:21396959:TG:T | donor_gain | 0.9800 |
| 20:21396957:CTTGA:C | donor_gain | 0.9700 |
| 20:21396534:C:CC | acceptor_gain | 0.9500 |
| 20:21396532:GACT:G | acceptor_gain | 0.9400 |
| 20:21396533:ACTG:A | acceptor_gain | 0.9400 |
| 20:21396531:AGAC:A | acceptor_gain | 0.9300 |
| 20:21396530:GAGAC:G | acceptor_gain | 0.9200 |
| 20:21396534:CTGG:C | acceptor_gain | 0.9200 |
| 20:21396532:GA:G | acceptor_gain | 0.8800 |
| 20:21396535:T:A | acceptor_gain | 0.8800 |
| 20:21396529:GGAGA:G | acceptor_gain | 0.8600 |
| 20:21396950:CCTCT:C | donor_loss | 0.8500 |
| 20:21396951:CTCTC:C | donor_loss | 0.8500 |
| 20:21396952:TCTCA:T | donor_loss | 0.8500 |
| 20:21396953:CTCAC:C | donor_loss | 0.8500 |
| 20:21396954:T:TA | donor_loss | 0.8500 |
| 20:21396955:C:CC | donor_loss | 0.8500 |
| 20:21396956:ACT:A | donor_loss | 0.8500 |
| 20:21396957:C:CG | donor_loss | 0.8500 |
| 20:21397023:T:TA | donor_gain | 0.8500 |
| 20:21396533:AC:A | acceptor_loss | 0.8300 |
| 20:21396534:C:A | acceptor_loss | 0.8300 |
| 20:21396535:T:C | acceptor_loss | 0.8300 |
| 20:21396530:GAGA:G | acceptor_gain | 0.8100 |
| 20:21397324:T:TA | donor_gain | 0.8100 |
| 20:21396548:C:T | acceptor_gain | 0.7900 |
| 20:21396968:G:C | donor_gain | 0.7900 |
| 20:21396536:G:C | acceptor_loss | 0.7700 |
AlphaMissense
2250 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:21396241:T:A | K245N | 1.000 |
| 20:21396241:T:G | K245N | 1.000 |
| 20:21396242:T:A | K245I | 1.000 |
| 20:21396243:T:C | K245E | 1.000 |
| 20:21396247:C:A | K243N | 1.000 |
| 20:21396247:C:G | K243N | 1.000 |
| 20:21396248:T:A | K243M | 1.000 |
| 20:21396248:T:G | K243T | 1.000 |
| 20:21396249:T:C | K243E | 1.000 |
| 20:21396249:T:G | K243Q | 1.000 |
| 20:21396251:T:C | Y242C | 1.000 |
| 20:21396252:A:C | Y242D | 1.000 |
| 20:21396252:A:G | Y242H | 1.000 |
| 20:21396254:C:G | R241P | 1.000 |
| 20:21396254:C:T | R241Q | 1.000 |
| 20:21396255:G:A | R241W | 1.000 |
| 20:21396255:G:C | R241G | 1.000 |
| 20:21396257:T:G | H240P | 1.000 |
| 20:21396258:G:C | H240D | 1.000 |
| 20:21396258:G:T | H240N | 1.000 |
| 20:21396259:G:C | N239K | 1.000 |
| 20:21396259:G:T | N239K | 1.000 |
| 20:21396260:T:A | N239I | 1.000 |
| 20:21396260:T:C | N239S | 1.000 |
| 20:21396260:T:G | N239T | 1.000 |
| 20:21396261:T:C | N239D | 1.000 |
| 20:21396261:T:G | N239H | 1.000 |
| 20:21396262:C:A | Q238H | 1.000 |
| 20:21396262:C:G | Q238H | 1.000 |
| 20:21396263:T:C | Q238R | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000412367 (20:21396419 G>A,T), RS1000786079 (20:21395743 C>G,T), RS1002070964 (20:21399204 C>A), RS1002138717 (20:21397782 C>T), RS1004294591 (20:21397965 G>C), RS1004304488 (20:21397130 GGCC>G,GGCCGCC,GGCCGCCGCC), RS1004578699 (20:21395531 T>C), RS1004631099 (20:21395230 T>A), RS1005939756 (20:21398051 T>C), RS1006052606 (20:21397261 C>A,T), RS1006695680 (20:21395355 A>G), RS1007414763 (20:21398622 C>T), RS1007666168 (20:21395121 A>G), RS1007881249 (20:21398315 T>C), RS1008220612 (20:21397486 AGCTGAG>A)
Disease associations
OMIM: gene MIM:607808 | disease phenotypes: MIM:256450
GenCC curated gene-disease
Mondo (1): hyperinsulinemic hypoglycemia, familial, 1 (MONDO:0009734)
Orphanet (2): Autosomal dominant hyperinsulinism due to SUR1 deficiency (Orphanet:276575), Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency (Orphanet:276598)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002479_15 | Lupus nephritis in systemic lupus erythematosus | 5.000000e-06 |
| GCST007556_21 | Autism spectrum disorder | 3.000000e-07 |
| GCST009391_521 | Metabolite levels | 4.000000e-06 |
| GCST010988_318 | Adult body size | 8.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010117 | pyruvate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | increases phosphorylation | 1 |
| butyraldehyde | increases expression | 1 |
| abrine | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hyperinsulinemic hypoglycemia, familial, 1, lupus nephritis